Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- H00005324-M02 - Provider product page
- Provider
- Novus Biologicals
- Proper citation
- Novus Cat#H00005324-M02, RRID:AB_2164898
- Product name
- Mouse Monoclonal PLAG1 Antibody
- Antibody type
- Monoclonal
- Description
- IgG purified.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Submitted references Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms.
Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement.
PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart.
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
Arias-Stella JA 3rd, Benayed R, Oliva E, Young RH, Hoang LN, Lee CH, Jungbluth AA, Frosina D, Soslow RA, Antonescu CR, Ladanyi M, Chiang S
The American journal of surgical pathology 2019 Mar;43(3):382-388
The American journal of surgical pathology 2019 Mar;43(3):382-388
PLAG1, SOX10, and Myb Expression in Benign and Malignant Salivary Gland Neoplasms.
Lee JH, Kang HJ, Yoo CW, Park WS, Ryu JS, Jung YS, Choi SW, Park JY, Han N
Journal of pathology and translational medicine 2019 Jan;53(1):23-30
Journal of pathology and translational medicine 2019 Jan;53(1):23-30
Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S, von Holstein SL, Homøe P, Heegaard S
Acta ophthalmologica 2018 Nov;96(7):e768-e771
Acta ophthalmologica 2018 Nov;96(7):e768-e771
Thalidomide-based induction regimens are as effective as bortezomib-based regimens in elderly patients with multiple myeloma with cereblon expression.
Jung SH, Choi HJ, Shin MG, Lee SS, Hwang EC, Jung TY, Cho MS, Yang DH, Ahn JS, Kim YK, Kim HJ, Lee JJ
Annals of hematology 2016 Oct;95(10):1645-51
Annals of hematology 2016 Oct;95(10):1645-51
Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement.
Bahrami A, Dalton JD, Bangalore S, Henry C, Krane JF, Navid F, Ellison DW
Head and neck pathology 2012 Sep;6(3):377-83
Head and neck pathology 2012 Sep;6(3):377-83
PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A, Dalton JD, Shivakumar B, Krane JF
Head and neck pathology 2012 Sep;6(3):328-35
Head and neck pathology 2012 Sep;6(3):328-35
A subset of cutaneous and soft tissue mixed tumors are genetically linked to their salivary gland counterpart.
Bahrami A, Dalton JD, Krane JF, Fletcher CD
Genes, chromosomes & cancer 2012 Feb;51(2):140-8
Genes, chromosomes & cancer 2012 Feb;51(2):140-8
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.
Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, Debey-Pascher S, Schulz A, Frenzel LP, Claasen J, Kutsch N, Krause G, Mayr C, Rosenwald A, Plass C, Schultze JL, Hallek M, Wendtner CM
Blood 2009 Oct 8;114(15):3255-64
Blood 2009 Oct 8;114(15):3255-64
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- Western Blot: PLAG1 Antibody (3B7) [H00005324-M02] - Western Blot detection against Immunogen (36.52 KDa) .
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- ELISA: PLAG1 Antibody (3B7) [H00005324-M02] - Detection limit for recombinant GST tagged PLAG1 is approximately 0.03ng/ml as a capture antibody.